Research Output per year
Fingerprint Dive into the research topics where Mitesh J Borad is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 28 Similar Profiles
Neoplasms
Medicine & Life Sciences
Cholangiocarcinoma
Medicine & Life Sciences
gemcitabine
Medicine & Life Sciences
Genes
Chemical Compounds
Tumors
Chemical Compounds
Atlases
Medicine & Life Sciences
Pancreatic Neoplasms
Medicine & Life Sciences
Genome
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
Phase 1 Study of VSV-hIFN-B for the Treatment of Hepatocellular Carcinoma
Project: Research project
Research Output 2003 2019
Clinicopathological features and outcomes of fibrolamellar hepatocellular carcinoma
Chakrabarti, S., Tella, S. H., Kommalapati, A., Huffman, B. M., Yadav, S., Riaz, I. B., Goyal, G., Mody, K., Borad, M. J., Cleary, S., Smoot, R. L. & Mahipal, A., Jan 1 2019, In : Journal of Gastrointestinal Oncology. 10, 3, p. 554-561 8 p.Research output: Contribution to journal › Article
Survival
Recurrence
Fibrolamellar hepatocellular carcinoma
Cell Death
Phosphotransferases
Decline in the seroprevalence of syphilis markers among first-time blood donors in Libreville (Gabon) between 2004 and 2016
Bisseye, C., Eko Mba, J. M., Ntsame Ndong, J. M., Kosiorek, H. E., Butterfield, R. J., Mombo, L. E., M'Batchi, B., Borad, M. J., Nagalo, B. M. & Allain, J. P., Feb 8 2019, In : BMC Public Health. 19, 1, 167.Research output: Contribution to journal › Article
Gabon
Seroepidemiologic Studies
Syphilis
Blood Donors
Odds Ratio
2
Citations
(Scopus)
Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers: A Phase 2 Clinical Trial
Shroff, R. T., Javle, M. M., Xiao, L., Kaseb, A. O., Varadhachary, G. R., Wolff, R. A., Raghav, K. P. S., Iwasaki, M., Masci, P., Ramanathan, R. K., Ahn, D., Bekaii-Saab, T. & Borad, M. J., Jan 1 2019, In : JAMA Oncology.Research output: Contribution to journal › Article
gemcitabine
Biliary Tract Neoplasms
Nanoparticles
Cisplatin
Clinical Trials
13
Citations
(Scopus)
Hepatocytes direct the formation of a pro-metastatic niche in the liver
Lee, J. W., Stone, M. L., Porrett, P. M., Thomas, S. K., Komar, C. A., Li, J. H., Delman, D., Graham, K., Gladney, W. L., Hua, X., Black, T. A., Chien, A. L., Majmundar, K. S., Thompson, J. C., Yee, S. S., O’Hara, M. H., Aggarwal, C., Xin, D., Shaked, A., Gao, M. & 9 others, , Mar 14 2019, In : Nature. 567, 7747, p. 249-252 4 p.Research output: Contribution to journal › Letter
Hepatocytes
Liver
STAT3 Transcription Factor
Neoplasm Metastasis
Circulating Neoplastic Cells
Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysis
Yadav, S., Xie, H., Bin-Riaz, I., Sharma, P., Durani, U., Goyal, G., Borah, B. J., Borad, M. J., Smoot, R. L., Roberts, L. R., Go, R. S., Mc Williams, R. R. & Mahipal, A., Jan 1 2019, In : European Journal of Surgical Oncology.Research output: Contribution to journal › Article
Propensity Score
Cholangiocarcinoma
Adjuvant Chemotherapy
Drug Therapy
Survival